In the dazzling constellation of global business innovation, the highly anticipated Hurun Future Unicorn Series – the “2024 Hurun Global Gazelle Index”, released by the renowned Hurun Research Institute, was unveiled with great fanfare on January 8, 2025. The list reveals that 302 new companies have made the cut, with 77 in biotechnology, 29 in artificial intelligence, and 26 in health technology. This index identifies high-growth enterprises founded after 2000 that are most likely to reach a unicorn-level valuation of one billion US dollars within three years. This marks the fourth time that the Hurun Research Institute has published the “Global Gazelle Index,” which enjoys extensive influence and authority worldwide. The companies listed are considered the shining stars of their industries, symbolizing high potential and rapid growth in innovation.

Hzymes Biotech has been honored to make the list, thanks to its outstanding performance in the field of biotechnology. The significance of being included in the “2024 Hurun Global Gazelle Index” is immense. It represents not only the authoritative recognition by an international institution of Hanhai New Enzyme’s innovative achievements and rapid growth over the years but also signifies that Hanhai New Enzyme has successfully charted a new course in the global biotechnology competition. Its international reputation and industry influence have also been highly acknowledged on this occasion.

Since its inception, Hzymes Biotech has been committed to the forefront of biotechnology, focusing on the in-depth research and innovative application of enzyme preparations. Over the past decade, the scientific research team, driven by their boundless passion for biotechnology and solid professional knowledge, has overcome numerous technical challenges. Starting from basic enzymology research, they have gradually established their own technological system. By continuously enhancing the company’s innovation capabilities and increasing R&D investment, they have, after years of hard work, successfully built a complete industrial ecosystem that covers research, production, sales, and services. Their products are widely used in core areas such as biomedicine and in vitro diagnostics. They have not only rapidly developed and secured an important position in the domestic market but have also begun to make their mark in the international market, expanding their overseas footprint. They will continue to strive to become a global leader in the core technologies of the biotechnology industry!

Hurun Group Chairman and Chief Researcher Rupert Hoogewerf presented honors to the representatives of the outstanding listed companies at the Beijing Yizhuang · 2025 Hurun Global Gazelle Enterprise Conference held in the Beijing Economic-Technological Development Area. Hundreds of guests were present to witness this significant milestone on the path to glory for these enterprises.

Mr. Hoogewerf stated: “Hurun Gazelles” and “Hurun Cheetahs” are two lists preceding the “Hurun Unicorn” list. “Hurun Gazelles” are dedicated to identifying start-ups from around the globe that have the highest potential to grow into unicorns within the next three years. “Hurun Gazelles” are among the most exciting companies in the world. Gazelles are known for their agility and astonishing burst of speed, reaching nearly 100 kilometers per hour. Similarly, “Hurun Gazelles” must run fast, otherwise – just like gazelles in nature – they might be eaten and fail to ascend to the status of a Hurun Unicorn.

Looking ahead, Hzymes will take this honor as a new starting point. In the future, it will continue to forge ahead, constantly drawing inspiration, broadening its horizons, deepening cooperation, and continuously exploring innovation in the field of biotechnology. At the same time, it will also strive towards the goal of becoming a global leader in the biotechnology industry, contributing more to the well-being of human health!